Evidence map›Paper›PMID 33431416›Full record

ArticleAntimicrobial agents and chemotherapy2021

Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program.

Michael A Pfaller, Shawn A Messer, Lalitagauri M Deshpande, Paul R Rhomberg, Eric A Utt, Mariana Castanheira

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Innovative antifungal strategies to combat drug-resistantFrontiers in cellular and infection microbiology · 2025
    Review
  7. Article
  8. Recent increase inAntimicrobial agents and chemotherapy · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Virulence Traits and Azole Resistance in KoreanJournal of fungi (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Clorgyline Analogs Synergize with Azoles against Drug Efflux inJournal of fungi (Basel, Switzerland) · 2023
    Article
  15. Clonal Diversity ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Evaluation of the synergistic antifungal activity of micafungin and voriconazole plus sertraline against Candida auris.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Article
  18. Article
  19. Review
  20. New Perspectives on Antimicrobial Agents: Isavuconazole.Antimicrobial agents and chemotherapy · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Michael A PfallerJMI Laboratories, North Liberty, Iowa, USA.
Shawn A MesserJMI Laboratories, North Liberty, Iowa, USA.
Lalitagauri M DeshpandeJMI Laboratories, North Liberty, Iowa, USA.
Paul R RhombergJMI Laboratories, North Liberty, Iowa, USA.
Eric A UttHospital Business Unit, Pfizer Inc., Groton, Connecticut, USA.
Mariana CastanheiraJMI Laboratories, North Liberty, Iowa, USA mariana-castanheira@jmilabs.com.ORCID 0000-0003-0126-1782
JMI Laboratories · USPfizer (United States) · USUniversity of Iowa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A total of 15

Indexed as

CandidaEchinocandinsAnidulafunginAntifungal AgentsColombiaDrug Resistance, FungalDrug SynergismGermanyMicrobial Sensitivity TestsMultilocus Sequence TypingNitrilesPyridinesTriazolesVoriconazoleAnidulafunginAntifungal AgentsEchinocandinsisavuconazoleNitrilesPyridinesTriazolesVoriconazoleazolesCandida aurisechinocandinssynergy testing

Identifiers

PMID33431416
PMCPMC8097481
OpenAlexW3118387144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.